10
Mar

After a big mid-stage failure cast doubt on its lead drug, biotech Cerulean Pharma is betting the nano treatment can succeed in other cancers, pitching a $75 million IPO bankroll further development.

…read more

Source: Cerulean pitches $75M IPO to give its cancer drug another shot

    

0 No comments